ConductScience.org, home

Paper12802201

Assessing disease onset and progression in the SOD1 mouse model of ALS.

Weydt P and 3 others. Neuroreport, 2003. Cited by 192 papers, by iCite.

Cite this record

ConductScience Library. Assessing disease onset and progression in the SOD1 mouse model of ALS. Papers, record 12802201. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12802201

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Assessing disease onset and progression in the SOD1 mouse model of ALS.
PubMed
Journal
Neuroreport
PubMed
Year
2003
PubMed
Publication types
Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
192
iCite
Relative citation ratio, by iCite
4.2
iCite
Revised in PubMed
2022-03-11
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Weydt PPatrick
2Hong SYSo Yon
3Kliot MMichel
4Möller TThomas

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Amyotrophic Lateral SclerosisMajor topic
Disease Models, AnimalMajor topic
Superoxide DismutaseMajor topic
Age of Onset
Animals
Disease Progression
Male
Mice
Mice, Transgenic
Psychomotor Performance

Source PubMed

Download CSV of topics

Cited by103

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 192 citations.

PMIDTitleJournalYearIn PapersSource
42883851Phenotypic Profiling of SOD1-G93A Mice: Integrating Sciatic Nerve Histopathology with Systemic Chemokine Dynamics During ALS Progression.Int J Mol Sci2026https://conductscience.org/library/papers/42883851PubMed
42350385Intravenous administration of an engineered AAV9-gene-silencing vector suppresses human SOD1 and extends survival in an ALS mouse model.Nat Commun2026https://conductscience.org/library/papers/42350385PubMed
41213972Development of a targeted BioPROTAC degrader selective for misfolded SOD1.Nat Commun2025https://conductscience.org/library/papers/41213972PubMed
40841608An Elongator mouse model of ALS spotlights TDP-43 in the motor neuron nucleolus.Commun Biol2025https://conductscience.org/library/papers/40841608PubMed
40356623Muscle-specific kinase levels in blood are an early diagnostic biomarker for SOD1-93A mouse model of ALS.Front Neurol2025https://conductscience.org/library/papers/40356623PubMed
39851451Enhanced Interleukin 6 Trans-Signaling Modulates Disease Process in Amyotrophic Lateral Sclerosis Mouse Models.Brain Sci2025https://conductscience.org/library/papers/39851451PubMed
38435120Intrathecal administration of a novel siRNA modality extends survival and improves motor function in the SOD1G93A ALS mouse model.Mol Ther Nucleic Acids2024https://conductscience.org/library/papers/38435120PubMed
38241160Nicotinamide riboside, pterostilbene and ibudilast protect motor neurons and extend survival in ALS mice.Neurotherapeutics2024https://conductscience.org/library/papers/38241160PubMed
37439013Potential effects of brain lipid binding protein in the pathogenesis of amyotrophic lateral sclerosis.Sci Prog2023https://conductscience.org/library/papers/37439013PubMed
37273905Development of abnormalities at the neuromuscular junction in the SOD1-G93A mouse model of ALS: dysfunction then disruption of postsynaptic structure precede overt motor symptoms.Front Mol Neurosci2023https://conductscience.org/library/papers/37273905PubMed
37252191Free fatty acids support oligodendrocyte survival in a mouse model of amyotrophic lateral sclerosis.Front Cell Neurosci2023https://conductscience.org/library/papers/37252191PubMed
37189613Oral Treatment with d-RD2RD2 Impedes Early Disease Mechanisms in SOD1*G93A Transgenic Mice but Does Not Prolong Survival.Biomedicines2023https://conductscience.org/library/papers/37189613PubMed
37049492Analysis of Feeding Behavior Characteristics in the Cu/Zn Superoxide Dismutase 1 (SOD1) SOD1G93A Mice Model for Amyotrophic Lateral Sclerosis (ALS).Nutrients2023https://conductscience.org/library/papers/37049492PubMed
369267315-Hydroxytryptamine: a potential therapeutic target in amyotrophic lateral sclerosis.Neural Regen Res2023https://conductscience.org/library/papers/36926731PubMed
36741054Comparing therapeutic modulators of the SOD1 G93A Amyotrophic Lateral Sclerosis mouse pathophysiology.Front Neurosci2022https://conductscience.org/library/papers/36741054PubMed
36619925Assessing the therapeutic impact of resveratrol in ALS SOD1-G93A mice with electrical impedance myography.Front Neurol2022https://conductscience.org/library/papers/36619925PubMed
36531135Endothelin-1, over-expressed in SOD1G93A mice, aggravates injury of NSC34-hSOD1G93A cells through complicated molecular mechanism revealed by quantitative proteomics analysis.Front Cell Neurosci2022https://conductscience.org/library/papers/36531135PubMed
36220871A novel assessment of fine-motor function reveals early hindlimb and detectable forelimb deficits in an experimental model of ALS.Sci Rep2022https://conductscience.org/library/papers/36220871PubMed
36042292BL-918, a small-molecule activator of ULK1, induces cytoprotective autophagy for amyotrophic lateral sclerosis therapy.Acta Pharmacol Sin2023https://conductscience.org/library/papers/36042292PubMed
35328829
Therapeutic Treatment of Superoxide Dismutase 1 (G93A) Amyotrophic Lateral Sclerosis Model Mice with Medical Ozone Decelerates Trigeminal Motor Neuron Degeneration, Attenuates Microglial Proliferation, and Preserves Monocyte Levels in Mesenteric Lymph Nodes.
Int J Mol Sci2022https://conductscience.org/library/papers/35328829PubMed

See all 103 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/12802201

GET https://conductscience.org/api/papers/v1/12802201/cited_by?page=2